Thema: US45773H4092
INO, US45773H4092
stock-5051155_1920.jpg - Foto: THN
Inovio Pharmaceuticals stock faces FDA decision for INO-3107
Inovio Pharmaceuticals stock remains focused on the FDA review of INO-3107. The decision concerns a rare respiratory disease.
ad-hoc-news.de, 30.10.26 20:53 Uhr
INO, US45773H4092
Piper Sandler keeps Buy rating for Inovio Pharmaceuticals ...
Five of eight analysts rate Inovio a Buy on October 27, 2026. Inovio Pharmaceuticals stock costs EUR 0.83 on October 27, 2026 in after-hours trading.
ad-hoc-news.de, 27.10.26 20:34 Uhr
INO, US45773H4092
Inovio faces October 30 FDA decision for Inovio Pharmaceuticals ...
FDA action on INO-3107 is set for October 30, 2026. Inovio Pharmaceuticals stock last traded at USD 0.90 on the Nasdaq on October 23, 2026.
ad-hoc-news.de, 24.10.26 19:53 Uhr
INO, US45773H4092
Inovio stock: Piper Sandler keeps USD 4.00 target for Inovio ...
Cash stood at USD 31.53 million on June 30, 2026. Inovio stock costs EUR 0.74 on October 22, 2026 at a USD 57.4 million market value.
ad-hoc-news.de, 22.10.26 19:11 Uhr
INO, US45773H4092
Zacks downgrades Inovio Pharmaceuticals stock to Hold with ...
Zacks cut Inovio to Hold on October 14, 2026. Inovio Pharmaceuticals stock costs EUR 0.89 on October 20, 2026 at Lang & Schwarz.
ad-hoc-news.de, 20.10.26 18:55 Uhr
INO, US45773H4092
Inovio Pharmaceuticals stock has November 9 earnings date ...
Cash was USD 31.53 million on June 30, 2026. Inovio Pharmaceuticals stock costs EUR 0.92 on October 15, 2026, up 5.05 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 22:37 Uhr
INO, US45773H4092
Inovio advances FDA review: Inovio Pharmaceuticals stock ...
FDA decision for INO-3107 is set for October 30, 2026. Inovio Pharmaceuticals stock costs EUR 1.02 after EUR 1.06, minus 3.77 percent.
ad-hoc-news.de, 05.10.26 15:55 Uhr
